Aducanumab: A Deep Dive into BIIB037 and its Impact A medication, initially known as BIIB037, is a notable attempt to combat mild Alzheimer's disease. Developed by Biogen, this molecule acts by removing beta-amyloid https://denisgate410980.pointblog.net/text-93125156